臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"yu c j"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 1271-1295 / 2308 (共93頁)
<< < 46 47 48 49 50 51 52 53 54 55 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2020-08-13T06:33:43Z	Identification of Five Driver Gene Mutations in Patients with Treatment-Na?ve Lung Adenocarcinoma in Taiwan	Yang T.-Y.; Chiu K.-L.; Hsu K.-H.; Ho C.-C.; Hsia T.-C.; Tseng J.-S.; Su K.-Y.; Wu M.-F.; Chang G.-C.; Yang P.-C.; Yu C.-J.; Chen K.-C.; Ooi H.; Wu T.-C.; Chen H.-J.; Chen H.-Y.; Chang C.-S.; Hsu C.-P.; Hsia J.-Y.; Chuang C.-Y.; Lin C.-H.; Chen J.J.W.; Chen K.-Y.; Liao W.-Y.; JIN-YUAN SHIH; Yu S.-L.
臺大學術典藏	2020-08-13T06:33:40Z	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Non-Small-Cell Lung Cancer Patients with Leptomeningeal Carcinomatosis	Liao B.-C.; Lee J.-H.; Lin C.-C.; Chen Y.-F.; Chang C.-H.; Ho C.-C.; JIN-YUAN SHIH; Yu C.-J.; Yang J.C.-H.
臺大學術典藏	2020-08-13T06:33:39Z	151P: Outcomes of research biopsies in clinical trials of EGFR mutation-positive NSCLC patients pretreated with EGFR-TKIs	Liao B.-C.; Bai Y.-Y.; Lin C.-C.; Lin S.-Y.; Lee Y.-F.; Ho C.-C.; JIN-YUAN SHIH; Chang Y.-C.; Yu C.-J.; Yang J.
臺大學術典藏	2020-08-13T06:33:39Z	Coexistence of EGFR T790M mutation and common activating mutations in pretreatment non-small cell lung cancer: A systematic review and meta-analysis	Chen L.-Y.;Molina-Vila M.A.;Ruan S.-Y.;Su K.-Y.;Liao W.-Y.;Yu K.-L.;Ho C.-C.;Jin-Yuan Shih;Yu C.-J.;Yang J.C.H.;Rosell R.;Yang P.-C.; Chen L.-Y.; Molina-Vila M.A.; Ruan S.-Y.; Su K.-Y.; Liao W.-Y.; Yu K.-L.; Ho C.-C.; JIN-YUAN SHIH; Yu C.-J.; Yang J.C.H.; Rosell R.; Yang P.-C.
臺大學術典藏	2020-08-13T06:33:39Z	Efficacy of pemetrexed-based chemotherapy in patients with ROS1 fusion-positive lung adenocarcinoma compared with in patients harboring other driver mutations in East Asian populations	Chen Y.-F.; Hsieh M.-S.; Wu S.-G.; Chang Y.-L.; Yu C.-J.; Yang J.C.-H.; Yang P.-C.; JIN-YUAN SHIH
臺大學術典藏	2020-08-13T06:33:37Z	Outcomes of cancer therapy administered to treatment-na?ve lung cancer patients in the intensive care unit	Lin J.-W.; Ho C.-C.; Yang C.-Y.; Chang C.-H.; Huang T.-M.; Chen C.-Y.; Chen K.-Y.; JIN-YUAN SHIH; Yu C.-J.; Chen Y.-F.; Chen Y.-F.;Lin J.-W.;Ho C.-C.;Yang C.-Y.;Chang C.-H.;Huang T.-M.;Chen C.-Y.;Chen K.-Y.;Jin-Yuan Shih;Yu C.-J.
臺大學術典藏	2020-08-13T06:33:34Z	Significant clinical factors associated with long-term mortality in critical cancer patients requiring prolonged mechanical ventilation	Chang H.-T.; Hsu C.-L.; Jerng J.-S.; Wang H.-C.; Kuo P.-H.; Wu H.-D.; JIN-YUAN SHIH; Yu C.-J.; Keng L.-T.;Chung K.-P.;Lin S.-Y.;Liang S.-K.;Cheng J.-C.;Chen I.-C.;Chen Y.-F.;Chang H.-T.;Hsu C.-L.;Jerng J.-S.;Wang H.-C.;Kuo P.-H.;Wu H.-D.;Jin-Yuan Shih;Yu C.-J.; Keng L.-T.; Chung K.-P.; Lin S.-Y.; Liang S.-K.; Cheng J.-C.; Chen I.-C.; Chen Y.-F.
臺大學術典藏	2020-08-13T06:33:34Z	Astrocyte-elevated gene-1 confers resistance to pemetrexed in non-small cell lung cancer by upregulating thymidylate synthase expression	Chen K.-Y.; Ho C.-C.; JIN-YUAN SHIH; Chang Y.-L.; Yu C.-J.; Yang P.-C.; Chen J.J.W.; Chen Y.-Y.; Chen C.-Y.; Chen C.-Y.;Chen Y.-Y.;Chen J.J.W.;Chen K.-Y.;Ho C.-C.;Jin-Yuan Shih;Chang Y.-L.;Yu C.-J.;Yang P.-C.
臺大學術典藏	2020-08-13T06:33:33Z	Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study	Yang J.C.-H.; Thress K.S.; Huang D.D.-R.; Bai Y.-Y.; Chang Y.-L.; Hsieh M.-S.; Su K.-Y.; Tsai T.-H.; Lee J.-H.; Liao W.-Y.; Ho C.-C.; Lin C.-C.; JIN-YUAN SHIH; Yu C.-J.; Lin C.-C.;Jin-Yuan Shih;Yu C.-J.;Ho C.-C.;Liao W.-Y.;Lee J.-H.;Tsai T.-H.;Su K.-Y.;Hsieh M.-S.;Chang Y.-L.;Bai Y.-Y.;Huang D.D.-R.;Thress K.S.;Yang J.C.-H.
臺大學術典藏	2020-08-13T06:33:33Z	Epidermal growth factor receptor mutation predicts favorable outcomes in non-small cell lung cancer patients with brain metastases treated with stereotactic radiosurgery	Chen K.-Y.; Liao W.-Y.; Yu C.-J.; Yang J.C.-H.; Kuo S.-H.; Cheng J.C.-H.; Yang P.-C.; Hsu F.-M.; Tseng H.-M.; Chen Y.-F.; Yang W.-C.; Xiao F.; JIN-YUAN SHIH; Ho C.-C.; Yang W.-C.;Xiao F.;Jin-Yuan Shih;Ho C.-C.;Chen Y.-F.;Tseng H.-M.;Chen K.-Y.;Liao W.-Y.;Yu C.-J.;Yang J.C.-H.;Kuo S.-H.;Cheng J.C.-H.;Yang P.-C.;Hsu F.-M.
臺大學術典藏	2020-08-13T06:33:33Z	Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan	Yang J.C.; Yu C.-J.; JIN-YUAN SHIH; Lin C.-C.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; Lee J.-H.; Chen K.-Y.; Liao W.-Y.; Lin S.-Y.;Yang C.-Y.;Liao B.-C.;Ho C.-C.;Liao W.-Y.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Hsu W.-H.;Su K.-Y.;Chang Y.-L.;Lee J.-H.;Lin C.-C.;Jin-Yuan Shih;Yang J.C.;Yu C.-J.; Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.
臺大學術典藏	2020-08-13T06:33:32Z	Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinum	Yu C.-J.; JIN-YUAN SHIH; Liao W.-Y.;Ho C.-C.;Tsai T.-H.;Chen K.-Y.;Jin-Yuan Shih;Yu C.-J.; Liao W.-Y.; Ho C.-C.; Tsai T.-H.; Chen K.-Y.
臺大學術典藏	2020-08-13T06:33:32Z	Outcomes of research biopsies in clinical trials of EGFR mutation-positive non-small cell lung cancer patients pretreated with EGFR-tyrosine kinase inhibitors	Liao B.-C.;Bai Y.-Y.;Lee J.-H.;Lin C.-C.;Lin S.-Y.;Lee Y.-F.;Ho C.-C.;Jin-Yuan Shih;Chang Y.-C.;Yu C.-J.;Chih-Hsin Yang J.;Yang P.-C.; Liao B.-C.; Bai Y.-Y.; Lee J.-H.; Lin C.-C.; Lin S.-Y.; Lee Y.-F.; Ho C.-C.; JIN-YUAN SHIH; Chang Y.-C.; Yu C.-J.; Chih-Hsin Yang J.; Yang P.-C.
臺大學術典藏	2020-08-13T06:33:31Z	Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non–Small-cell Lung Cancer Patients	Ho C.-C.; JIN-YUAN SHIH; Yu C.-J.; Yang J.C.-H.; Liao W.-Y.; Lin C.-C.; Lee J.-H.; Hsiue E.H.-C.; Wu T.-H.; Wu T.-H.;Hsiue E.H.-C.;Lee J.-H.;Lin C.-C.;Liao W.-Y.;Ho C.-C.;Jin-Yuan Shih;Yu C.-J.;Yang J.C.-H.
臺大學術典藏	2020-08-13T06:33:30Z	Treatment effectiveness and tolerability of afatinib at different doses in patients with EGFR-mutated lung adenocarcinoma: How low can we go?	Wei Y.-F.; Tsai M.-S.; Chen K.-Y.; JIN-YUAN SHIH; Yu C.-J.; Lim C.-K.; Lim C.-K.;Wei Y.-F.;Tsai M.-S.;Chen K.-Y.;Jin-Yuan Shih;Yu C.-J.
臺大學術典藏	2020-08-13T06:33:30Z	Driver mutations of young lung adenocarcinoma patients with malignant pleural effusion	JIN-YUAN SHIH; Yang J.C.-H.; Yu C.-J.; Liu Y.-N.; Wu S.-G.; Wu S.-G.;Liu Y.-N.;Yu C.-J.;Yang J.C.-H.;Jin-Yuan Shih
臺大學術典藏	2020-08-13T06:33:29Z	IGFBP7 Drives resistance to epidermal growth factor receptor tyrosine kinase inhibition in lung cancer	Hsu C.-L.; Liu Y.-N.; Tsai M.-F.; Chang T.-H.; Wu S.-G.; Wu S.-G.;Chang T.-H.;Tsai M.-F.;Liu Y.-N.;Hsu C.-L.;Chang Y.-L.;Yu C.-J.;Jin-Yuan Shih; Chang Y.-L.; Yu C.-J.; JIN-YUAN SHIH
臺大學術典藏	2020-08-13T06:33:28Z	Consecutive emergence of typical acquired resistance to EGFR tyrosine kinase inhibitors in a patient with metastatic pulmonary squamous cell carcinoma	Yang C.-Y.; Hsieh M.-S.; Liao W.-Y.; JIN-YUAN SHIH; Yu C.-J.
臺大學術典藏	2020-08-13T06:33:27Z	A rare epidermal growth factor receptor H773L/V774M compound mutation in advanced non-small-cell lung cancer with poor response to epidermal growth factor receptor tyrosine kinase inhibitor	Yang C.-Y.; Yu C.-J.; JIN-YUAN SHIH; Chen L.-C.; Chen L.-C.;Jin-Yuan Shih;Yu C.-J.;Yang C.-Y.
臺大學術典藏	2020-08-13T06:33:27Z	Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations	Yang J.C.-H.; Yu C.-J.; JIN-YUAN SHIH; Lin Z.-Z.; Lin Y.-T.; Chen J.-S.; Liao W.-Y.; Ho C.-C.; Hsu C.-L.; Yang C.-Y.; Chen K.-Y.; Lee J.-H.
臺大學術典藏	2020-08-13T06:33:25Z	Effectiveness of Treatments for Advanced Non–Small-Cell Lung Cancer With Exon 20 Insertion Epidermal Growth Factor Receptor Mutations	Wu J.-Y.; Yu C.-J.; JIN-YUAN SHIH
臺大學術典藏	2020-08-13T06:33:25Z	Clinical factors associated with treatment outcomes in EGFR mutant non-small cell lung cancer patients with brain metastases: A case-control observational study	JIN-YUAN SHIH; Yu C.-J.; Chen Y.-F.; Chen C.-Y.; Chen Y.-H.; Chen Y.-H.;Chen Y.-F.;Chen C.-Y.;Jin-Yuan Shih;Yu C.-J.
臺大學術典藏	2020-08-13T06:33:24Z	Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors	Tsai T.-H.; Chen K.-Y.; Ho C.-C.; Liao W.-Y.; Yang C.-Y.; Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Hsu C.-C.;Liao B.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Jin-Yuan Shih;Yang J.C.-H.;Yu C.-J.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; JIN-YUAN SHIH; Yang J.C.-H.; Yu C.-J.
臺大學術典藏	2020-08-13T06:33:24Z	Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib	Yu C.-J.; Yang J.C.-H.; JIN-YUAN SHIH; Lin C.-C.; Lee J.-H.; Hsu W.-H.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu C.-L.; Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Liu Y.-N.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Liao B.-C.;Hsu C.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Jin-Yuan Shih;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.
臺大學術典藏	2020-08-13T06:33:22Z	Complex EGFR mutations with secondary T790M mutation confer shorter osimertinib progression-free survival and overall survival in advanced non-small cell lung cancer	JIN-YUAN SHIH; Yu C.-J.; Liu Y.-N.; Wu S.-G.; Tsai T.-H.; Lin Y.-T.; Lin Y.-T.;Tsai T.-H.;Wu S.-G.;Liu Y.-N.;Yu C.-J.;Jin-Yuan Shih

顯示項目 1271-1295 / 2308 (共93頁)
<< < 46 47 48 49 50 51 52 53 54 55 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :2856708
	造訪人次 : 53592264 線上人數 : 774 教育部委託研究計畫計畫執行:國立臺灣大學圖書館